XORTX Therapeutics logo

XORTX Therapeutics

XRTX | NASDAQ
Chart Builder DCF Calculator
$1.04
-$0.06 (-5.45%)
At close: Nov 16, 2026, 4:00 PM ET
$1.01
-$0.03 (-2.88%)
After-hours: Nov 16, 2026, 7:57 PM ET
-5.45%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
20.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #990/1021 (Top 97%)

Key Statistics

Market Data

Market Cap $1.89M
1D Range
0.97 1.44
52W Range
0.84 3.24

Valuation (TTM)

PE -0.45
PB 0.37
EV/EBITDA -0.46

Valuation (NTM)

Forward PE 0.25
Forward PEG 0.01
Price Target $0.00
Loading financial charts...

Profile

XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to advancing and bringing to market medical treatments targeting a range of conditions, including chronic kidney ailments, diabetes, insul...

Sector Healthcare
Industry Biotechnology
Employees 2
IPO Date Sep 23, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.